QUANTUM X LABS INC. quarterly report, Q3 FY2014

QUANTUM X LABS INC. — 2014 Q3 Form 10-Q Summary

Entity identification: The supplied filing is for Zaxis International Inc., not Quantum X Labs Inc. Investors should verify that this is the intended filing. It covers the quarter and nine months ended September 30, 2014; interim financial statements are unaudited.

Business context

Zaxis reported that it had no current business operations and was a shell company. It was seeking a business combination but had not identified a target business or industry. Its former electrophoresis-products business ceased operations in 2002.

Financial results and position

MetricQ3 2014Q3 2013Nine months 2014Nine months 2013
Revenue$0$0$0$0
General and administrative expense$6,500$9,750$20,750$31,450
Interest expense$9,242$2,550$11,920$7,650
Net loss$(15,742)$(12,300)$(32,670)$(39,100)
Basic and diluted loss per share$(0.01)$(0.01)$(0.02)$(0.02)

At September 30, 2014, the company reported no assets and no cash, current liabilities of $177,518, long-term convertible notes of $125,000, and total liabilities of $302,518. Stockholders’ deficit was $302,518. Current liabilities included $6,500 of trade accounts payable, $35,039 of accrued interest, and $135,979 due to an unrelated party.

Net cash used in operations for the nine months was $40,000, funded by $40,000 of financing proceeds identified in the cash flow statement as borrowings on a convertible note. Cash remained zero. The company reported no investing cash flows.

Changes and notable items

  • Nine-month net loss narrowed by $6,430 year over year, as lower general and administrative expenses more than offset higher interest expense. Q3 net loss increased by $3,442 year over year, principally alongside higher interest expense.
  • The MD&A narrative contains an apparent inconsistency: it says Q3 general and administrative expense increased by $3,250, although the financial statements show a decrease from $9,750 to $6,500. Investors should rely on and verify the underlying statements.
  • In March 2014, the company amended and transferred notes previously held by its president and principal shareholder to unaffiliated parties. The notes’ interest rates were reduced from 12% to 1%, conversion prices were changed, and maturities extended to July 1, 2016. At September 30, fifteen notes totaling $125,000 were outstanding at 1% interest. A separate $40,000 note issued for services was also described; its conversion price is $0.005 per share.
  • On March 25, 2014, the president assigned $124,229 of advances and accruals due to him to an unaffiliated third party. The balance sheet reports $135,979 due to an unrelated party at quarter-end.
  • Common shares outstanding were 1,695,126 at September 30 and November 6, 2014. Management stated it owned 82% of outstanding shares and warned that financing or a business combination could substantially dilute existing shareholders or change control.

Outlook, risks, and controls

Management’s plan was to use limited resources to seek a business combination; no target or financing commitment had been secured. Management cited potential acquisition opportunities but provided no quantified guidance. It warned that financing might not be available on acceptable terms and that completing a combination could require substantial share issuance. A combination could involve an early-stage or financially unstable business, and the company may have limited ability to diversify.

The filing states that accumulated losses, negative operating cash flow, and absence of revenue raise substantial doubt about the company’s ability to continue as a going concern. The financial statements include no adjustments for that uncertainty. Disclosure controls were deemed ineffective because of a lack of segregation of duties; no material change in internal control over financial reporting was reported during the quarter. The filing reported no legal proceedings, unregistered equity sales, or defaults upon senior securities.

Key facts for investors to verify

  • Whether this Zaxis International Inc. filing is the intended filing for Quantum X Labs Inc.
  • The amounts, holders, maturity dates, and conversion terms of the outstanding notes and advances, including potential dilution.
  • The apparent Q3 expense narrative inconsistency and the relationship between the $40,000 financing cash flow and the convertible note disclosures.
  • How the company expects to fund ongoing costs and pursue a business combination given zero cash, no revenue, and substantial doubt about going concern.
  • Whether disclosure-control deficiencies have been addressed and whether management’s reported ownership remains current.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.